Metraipolis › archive › dc_997f159929be

Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity… — Europe PMC PMID:41155717

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155717
DOI
10.3390/medicina61101730
License (as archived)
solo-consultazione
Archived
2026-11-09T19:44:25.921Z
SHA-256 of the archived text
de611640ff38e4ad6e8b9a138a99b940b59f2532d9b8edb4dc8d78315f61968a
Stable URL of this page
https://metraipolis.com/documento/dc_997f159929be

How to cite

Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity… — Europe PMC PMID:41155717 — Europe PMC (en), https://europepmc.org/article/MED/41155717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_997f159929be (Metraipolis archive dc_997f159929be, sha256 de611640ff38e4ad6e8b9a138a99b940b59f2532d9b8edb4dc8d78315f61968a)
BibTeX
@misc{dc997f159929be,
  title = {Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity… — Europe PMC PMID:41155717},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155717},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_997f159929be; sha256 de611640ff38e4ad6e8b9a138a99b940b59f2532d9b8edb4dc8d78315f61968a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155717. Agents can read the archived copy with the MCP tool read_document.